Table 3.
Q1 | Q2 | Q3 | Q4 | p (continuous scale) | |
---|---|---|---|---|---|
Quartiles ranges |
48 - 93 |
94 - 113 |
114 - 162 |
163 - 600 |
|
Patients with events/ all patients |
36/418 |
35/418 |
29/419 |
36/418 |
|
Model 1 |
reference |
1.00 (0.63 - 1.60) |
0.85 (0.52 - 1.39) |
1.03 (0.65 - 1.64) |
p=0.57 |
|
|
p=0.99 |
p=0.51 |
p=0.89 |
|
Model 2 |
reference |
1.11 (0.67 - 1.83) |
0.96 (0.57 - 1.62) |
1.13 (0.69 - 1.87) |
p=0.38 |
p=0.69 | p=0.87 | p=0.63 |
Model 1: adjusted on age and sex; model 2: adjusted on age, sex, acute coronary syndrome, smoking status, body mass index, diabetes, hypertension, HDL-cholesterol, triglyceride, CRP, number of stenosed vessels, and medication use (heparin, beta-blockers, ACE-inhibitors, calcium antagonists and statins). P-value was calculated on continuous log-transformed sEPCR.